SCHEMBL7181752

SCHEMBL7181752

OC[C@H]1O[C@H](Oc2ccccc2O)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.69

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC28A3 Q9HAS3 3/20 0.69
HIF1A Q16665 1/20 0.63
TYR P14679 3/20 0.61
ATM Q13315 1/20 0.59
SLC5A2 P31639 5/20 0.59
SLC5A1 P13866 3/20 0.57
EPHX2 P34913 1/20 0.53
CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664789 1.00 SLC28A3 (0.69) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL8657750 1.00 SLC28A3 (0.69) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL2923796 1.00 SLC28A3 (0.69) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL166162 1.00 SLC28A3 (0.69) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL1706261 1.00 SLC28A3 (0.69) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL2917655 0.98 SLC28A3 (0.68) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL13324378 0.98 SLC28A3 (0.68) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL2927767 0.98 SLC28A3 (0.68) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL3662700 0.98 SLC28A3 (0.68) SLC28A3HIF1ATYRATMSLC5A2
SCHEMBL12610461 0.89 SLC28A3 (0.71) SLC28A3HIF1ATYRATMSLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116370485-B Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of medicine for treating osteoporosis 暨南大学附属第一医院(广州华侨医院) 2024-04-19 CN claimed
CN-116370485-A Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of reagent for promoting vascular-bone formation 暨南大学附属第一医院(广州华侨医院) 2023-07-04 CN claimed
CN-116370485-B Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of medicine for treating osteoporosis 暨南大学附属第一医院(广州华侨医院) 2024-04-19 CN disclosed
CN-116370485-B Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of medicine for treating osteoporosis 暨南大学附属第一医院(广州华侨医院) 2024-04-19 CN disclosed
CN-116370485-B Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of medicine for treating osteoporosis 暨南大学附属第一医院(广州华侨医院) 2024-04-19 CN disclosed
CN-116370485-A Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of reagent for promoting vascular-bone formation 暨南大学附属第一医院(广州华侨医院) 2023-07-04 CN disclosed
CN-116370485-A Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of reagent for promoting vascular-bone formation 暨南大学附属第一医院(广州华侨医院) 2023-07-04 CN disclosed
CN-116370485-A Application of 2-hydroxyphenyl alpha-D-glucopyranoside in preparation of reagent for promoting vascular-bone formation 暨南大学附属第一医院(广州华侨医院) 2023-07-04 CN disclosed
EP-1289489-A2 TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE PENTAPHARM Ltd. (CH) 2003-03-12 EP disclosed
WO-2001091715-A2 TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE PENTAPHARM LTD. (CH) 2001-12-06 WO disclosed
US-5766267-A USING FIBER REACTIVE DYES HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-16 US disclosed
EP-0745719-A2 Use of carbohydrate compounds as auxiliary agents in the dyeing or printing of fibrous materials HOECHST AKTIENGESELLSCHAFT (DE) 1996-12-04 EP disclosed